Monthly News Roundup - March 2024

Rezdiffra Approved as First Drug for Nonalcoholic Fatty Liver Disease (NASH)  In March, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Rezdiffra (resmetirom) for adults with noncirrhotic nonalcoholic...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news